BrainStorm Cell Therapeutics Inc.
Tel Aviv
455 articles about BrainStorm Cell Therapeutics Inc.
-
BrainStorm Cell Therapeutics Inc. Receives 1.2 Million NIS Grant From Israel's Office of the Chief Scientist
6/4/2013
-
BrainStorm Cell Therapeutics Inc. Announces CEO Interview With The Wall Street Analyst
5/23/2013
-
BrainStorm Cell Therapeutics Inc. to Present at Several Scientific and Investment Conferences
4/10/2013
-
BrainStorm Cell Therapeutics Inc. Partners With Dana-Farber Cancer Institute for NurOwn Production in Phase II ALS Clinical Trial
4/8/2013
-
BrainStorm Cell Therapeutics Inc. Release: Results of NurOwn Clinical Trial Suggest Efficacy in ALS Patients
3/21/2013
-
Phase II ALS Clinical Trial With BrainStorm Cell Therapeutics Inc.'s NurOwn to be Expanded to a Third Premiere U.S. Clinical Site
3/18/2013
-
BrainStorm Cell Therapeutics Inc. Presents Breakthrough Phase I/II ALS Clinical Data at the American Academy of Neurology Annual Meeting
3/13/2013
-
BrainStorm Cell Therapeutics Inc. Presents at the 11th International Conference on Alzheimer's and Parkinson's Disease
3/11/2013
-
BrainStorm Cell Therapeutics Inc. to Present at the 8th Annual New York Stem Cell Summit
2/13/2013
-
BrainStorm Cell Therapeutics Inc. Announces Private Equity Financing of $250,000 With Individual Private Investor
2/11/2013
-
BrainStorm Cell Therapeutics Inc. Appoints Alon Natanson as CEO
1/28/2013
-
BrainStorm Cell Therapeutics Inc.’s CEO Issues Annual Letter to Shareholders
1/23/2013
-
BrainStorm Cell Therapeutics Inc. Establishes Safety of Repeat Doses of NurOwn in Mice; Pre-clinical Study Conducted at GLP-Compliant Harlan Laboratories, Inc.
1/10/2013
-
BrainStorm Cell Therapeutics Inc. Achieves Important New Development for Commercialization of NurOwn
1/9/2013
-
BrainStorm Cell Therapeutics Inc.'s Clinical Trial is Fast-Tracked to Phase IIa, Representing a Major Milestone for the Company
1/7/2013
-
BrainStorm Cell Therapeutics Inc. Announces New Shareholders Conference Call Date to Discuss Upcoming Positive Developments
1/3/2013
-
BrainStorm Cell Therapeutics Inc. and Octane to Develop Revolutionary Bioreactor-Based NurOwn Stem Cells Production Process
12/17/2012
-
BrainStorm Cell Therapeutics Inc. Receives 3 Million NIS Grant From Israel’s Office of the Chief Scientist
12/12/2012
-
BrainStorm Cell Therapeutics Inc.’s Outstanding ALS Clinical Data Chosen to Kick-Off the Israel Neurological Association Meeting
12/11/2012
-
BrainStorm Cell Therapeutics Inc. Deferring Shareholders Conference Call in Anticipation of Upcoming Developments
12/10/2012